Gene Query: QARS

Dataset Description Geneva Score
Genome wide expression change by RNF168 knocking down in NEC cells 53.8
Genome wide expression change by RNF168 knocking down in MCF-7 cells 45.22
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 43.35
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 40.32
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 35.79
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 35.79
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 31.9
Active translatome profiling with RiboLace in MCF7 cells 31.84
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 30.35
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 29.94
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 28.85
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 28.11
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 26.45
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 23.17
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 22.56
Genome-wide functional assessment of enhancer activities in the human genome 21.83
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 20.23
3’ Uridylation Expands miRNA Target Repertoire 20.13
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 20.0
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 19.89
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 19.85
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 19.85
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 19.34
O-glcnAc reprograms cellular energetics 19.22
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 19.08
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 18.89
RNA-seq in transgenic cells 18.87
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 18.64
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 18.42
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 18.36
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 18.11
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 18.11
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 17.14
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 17.04
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 16.93
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 16.93
Expression profiling of etoposide-induced senescent cells 16.65
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 16.51
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 16.25
RNA-sequencing of human tendon after injury 16.23
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 16.04
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 16.04
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 16.02
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 15.93
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 15.91
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 15.56
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 15.56
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 15.23
Molecular Mechanisms of Endothelial Hyperpermeability 15.2
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 15.16
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 15.02
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 15.02
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 14.69
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 14.56
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 14.34
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 14.34
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 14.16
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 14.16
Identification of transcription start sites for human A549 cell line using ReCappable-seq 14.09
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 14.05
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 13.83
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 13.82
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 13.73
Effect of mitochondria deficiency on senescence-associated gene expression 13.67
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 13.63
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 13.62
Regulation of Lipids is Central to Replicative Senescence 13.56
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 13.54
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 13.53
Knockdown of ADNP in HCT116 colon cancer cells 13.49
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 13.45
Genome wide miR-191 target profile determined by RIP and gene expression profiling 13.45
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 13.45
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 13.42
LncRNA expression profiling of ischemic stroke patients 13.32
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 13.31
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 13.24
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 13.24
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 13.23
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 13.14
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 13.13
Mitochondrial dsRNA triggers antiviral signalling in humans 12.83
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 12.79
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.66
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 12.56
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 12.28
Systematic discovery of endogenous human ribonucleoprotein complexes 12.26
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 12.18
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 12.02
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.94
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 11.89
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 11.87
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.8
Lipid degradation promotes prostate cancer cell survival 11.79
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.77
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 11.65
An RNA-centric dissection of host complexes controlling flavivirus infection 11.52
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 11.52
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 11.51
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 11.5
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 11.22
RNA m5C Methylation in breast cancer using MeRIP-Seq 11.22
Short and Long RNA sequencing of human mature erythrocytes 11.16
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.99
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.99
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 10.95
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 10.87
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.81
Effect of Influenza virus infection on lncRNA expression in A549 cells 10.81
U1 snRNP telescripting regulates size-function stratified human genome 10.77
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 10.77
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 10.68
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.61
RNA-seq of YB5 cells treated with Proscillaridin A 10.57
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.55
The transcriptome and chromatin accessbility landscape of mammalian germline 10.52
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 10.52
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 10.42
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 10.37
Reassessment of Exosome Composition 10.26
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 10.24
Expression by CD133+ cells isolated from the adult human exocrine pancreas 10.23
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 10.16
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 10.16
Identification of Atrial Fibrillation associated genes and functional non-coding variants 10.11
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 10.1
RNA-sequencing in irradiated and normal A549 cells. 10.09
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 10.06
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 10.06
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 10.05
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 10.05
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 9.96
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 9.94
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 9.93
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.92
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 9.91
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 9.91
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 9.89
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 9.89
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 9.73
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 9.7
T47D RNA-seq and ChrRNA-seq data 9.7
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 9.68
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 9.68
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 9.68
BAF controls genome accessibility 9.66
A transcriptome-wide divergence in protein translation scales with LIN28B expression 9.65
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 9.64
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 9.63
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 9.6
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 9.58
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.56
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 9.54
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.48
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 9.47
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 9.42
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 9.42
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.34
RNA-seq of tumor cells following angiopellosis extravasation 9.28
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 9.28
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 9.28
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 9.24
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.12
Transcriptome analysis of Zika infected neural stem cells 9.11
Zika infected neural stem cells 9.11
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 9.11
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.11
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 9.01
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 9.01
MYC dependent mRNA translation shapes gene expression and cell biology 9.01
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.98
SNHG5 siRNA knock down in HCT116 cells 8.97
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.97
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 8.9
Profiling of escape kinetics of viruses subjected to RNAi 8.87
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.86
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 8.83
Oncogenic MYC induces a dependency on the spliceosome in human cancer 8.75
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 8.72
FOXD3 is a novel tumor suppressor in lung cancer 8.72
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 8.72
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 8.72
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 8.66
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 8.6
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.57
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 8.56
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.51
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.51
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 8.5
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.4
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 8.39
Single-nucleotide-resolution mapping of HBV promoters using CAGE 8.36
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.35
Developmental stage specific chromosome architecture in human erythroid cells 8.35
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.35
Analysis of transcriptional regulation by Myt1 and Myt1l 8.32
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.31
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 8.27
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 8.27
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 8.25
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 8.23
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 8.23
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.23
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 8.22
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.21
Widespread regulated alternative splicing of single codons accelerates proteome evolution 8.14
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 8.14
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 8.11
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 8.1
The human blood-nerve barrier transcriptome 8.09
RNA-seq analysis of differentiating human erythroblasts 8.05
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 8.03
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 7.98
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 7.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.98
WRN knockout effects upon gene expression in SW48 and OVK18 7.96
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 7.94
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 7.9
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.88
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 7.83
METTL3 and WTAP 7.81
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 7.81
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.81
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 7.8
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 7.74
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.71
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 7.69
RNA sequencing of primary human platelets and in vitro cell lines 7.66
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 7.63
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 7.61
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 7.61
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 7.58
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 7.58
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 7.56
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 7.55
Transcriptome of U251 cells overexpression complement component 7 7.42
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.34
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.34
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 7.33
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.32
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 7.31
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 7.29
Exploring the RNA landscape of endothelial exosomes 7.28
Modeling Familial Cancer with iPSC Approaches 7.24
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 7.23
Transcriptome wide analysis of classically and alternatively activated macrophages 7.21
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 7.2
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 7.15
ZIKV infection of monocytes activates inflammasome pathways 7.15
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.14
Ebola virus (EBOV) infection of ARPE-19 cells 7.1
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 7.05
Unique features and clinical importance of acute alloreactive immune responses 7.05
mRNA expression profile of Lymphocytes 7.03
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.95
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 6.94
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.91
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 6.91
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 6.91
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.76
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.69
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 6.58
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 6.58
Stem and effector CD8 T-cells from human cancers 6.57
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 6.45
Global analyses of the effect of different cellular contexts on microRNA targeting 6.45
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 6.45
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.44
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.44
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 6.42
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 6.4
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 6.38
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 6.37
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 6.37
The pioneer factor CEBPA modulates vitamin D signaling 6.37
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.29
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.25
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 6.17
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 6.13
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 6.1
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 6.09
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 6.0
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.96
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 5.92
BET bromodomain inhibition 5.69
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 5.69
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.66
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.65
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.65
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.64
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.63
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 5.59
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 5.59
Real-time observation of light-controlled transcription in living cells 5.58
SRSF1 role in cellular gene expression and splicing 5.56
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.49
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.45
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.45
Differential responses of human fetal brain neural stem cells to Zika virus infection 5.44
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 5.44
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.4
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.34
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.31
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 5.25
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 5.21
miR-93 Targets in Human Endothelial Cells 5.19
TT-Seq captures the human transient transcriptome 5.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.16
The pause-initiation limit restricts transcription activation in human cells 5.09
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.04
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.03
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.0
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.98
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.91
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 4.86
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.85
RNA-seq of MCF10A cells and CAF 4.85
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.81
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.78
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 4.76
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 4.74
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 4.73
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.67
NAPRT activation of macrophages 4.65
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.64
Landscape and variation of RNA secondary structure across the human transcriptome 4.63
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.61
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.59
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.5
Transcriptomic analysis of the HOTAIR-regulated genes 4.49
Transcription elongation regulates genome 3D structure 4.44
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.43
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 4.39
p63 controls the enhancer landscape during keratinocyte differentiation 4.39
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 4.38
Measure transcript integrity using RNA-seq data 4.38
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 4.37
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.36
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.32
RNA sequencing of human mammary epithelial cells 4.26
Iron response of HepG2 cells 4.26
Determining mRNA half-lives on a transcriptome-wide scale 4.26
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 4.24
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.23
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 4.23
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 4.21
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.2
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 4.12
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.08
Transcriptome analysis of peripheral blood monocytes 4.03
scRNASeq analysis of cycling cardiomyocytes 4.01
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 3.95
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.94
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.94
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.83
Expression profiling of MCF-7 cells with treatment of TCDD 3.83
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.8
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.74
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 3.65
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 3.59
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 3.59
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.55
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.5
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.37
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.35
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 3.32
The role of the Calcium-Sensing receptor in colorectal cancer 3.31
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 3.29
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.26
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.22
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.14
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.09
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.08
RNA-seq of RKO cells with cTAZ KO or putback 3.07
Next generation sequencing of small RNAs isolated from exosomes in human semen 3.06
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.03
Intron retention induced by microsatellite expansions as a disease biomarker. 2.98
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.87
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 2.81
RNA transcriptome analysis during HSV-1 infection 2.79
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 2.76
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.73
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.72
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.72
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.71
Total RNA-Seq data from leukemic patients with complex structural variants 2.68
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.66
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.65
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.61
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.56
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.55
Tracking distinct RNA populations using efficient and reversible covalent chemistry 2.54
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.49
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 2.48
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.46
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.42
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 2.42
Genome-wide analysis of the Integrator complex (HTS) 2.42
Genome-wide analysis of the Integrator complex 2.42
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.4
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.31
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.31
RNA Sequencing of Human iPS derived Cardiomyocytes 2.31
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.26
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.26
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.26
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.23
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.23
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.16
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.09
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.09
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.06
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.02
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.02
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.01
High-throughput sequencing of PROMPT-enriched samples. 2.01
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.0
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.96
Gene expression profiling of KSHV-infected periodontal ligament cells 1.92
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.92
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.92
Enhancer activation during EGF response 1.91
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.89
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.86
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.85
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.82
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.81
Differential gene expression profiles in imatinib-resistant cell lines 1.76
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.75
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.68
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.66
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.56
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.55
Transposon-based construction of strand-specific RNA-seq libraries 1.53
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.5
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.48
Hepatic transcriptome of pediatric hepatoblastoma. 1.46
Transcriptome profiling of 5 human adenocarcinoma cell lines 1.41
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.39
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.36
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.34
RNA-seq of primary patient AML samples 1.34
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.31
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.3
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.3
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.26
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.21
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.07
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.06
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.05
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.05
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.05
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.04
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.0
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.0
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.98
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.97
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.95
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.93
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.89
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.87
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.87
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.83
Transcriptome analysis of CNS leukemia 0.72
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.72
Finding missing proteins from epigenetically manipulated human cells 0.72
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.7
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.69
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.68
Metabolism as an early predictor of DPSCs aging 0.6
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.6
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.6
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.57
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.55
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.53
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.51
The role of m6A/m-RNA methylation in stress response regulation 0.42
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.42
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.42
SOX11 knockdown in B-ALL cell lines 0.4
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.36
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.36
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.36
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.35
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.3
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.26
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.25
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.25
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.24
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.24
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.19
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.15
6mer seed toxicity in viral microRNAs 0.11
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.1
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.1
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.05
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.02
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.02
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation